Characterization ofSalmonella entericaSerotype Newport Isolated from Humans and Food Animals
- 1 December 2003
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 41 (12), 5366-5371
- https://doi.org/10.1128/jcm.41.12.5366-5371.2003
Abstract
Salmonella enterica serotype Newport isolates resistant to at least nine antimicrobials (including extended-spectrum cephalosporins), known as serotype Newport MDR-AmpC isolates, have been rapidly emerging as pathogens in both animals and humans throughout the United States. Resistance to extended-spectrum cephalosporins is associated with clinical failures, including death, in patients with systemic infections. In this study, 87 Salmonella serotype Newport strains were characterized by pulsed-field gel electrophoresis (PFGE) and antimicrobial susceptibility testing and examined for the presence of class 1 integrons and blaCMY genes. Thirty-five PFGE patterns were observed with XbaI, and three of these patterns were indistinguishable among isolates from humans and animals. Fifty-three (60%) Salmonella serotype Newport isolates were identified as serotype Newport MDR-AmpC, including 16 (53%) of 30 human isolates, 27 (93%) of 29 cattle isolates, 7 (70%) of 10 swine isolates, and 3 (30%) of 10 chicken isolates. However, 28 (32%) Salmonella serotype Newport isolates were susceptible to all 16 antimicrobials tested. The blaCMY gene was present in all serotype Newport MDR-AmpC isolates. Furthermore, the plasmid-mediated blaCMY gene was transferable via conjugation to an Escherichia coli strain. The transconjugant showed the MDR-AmpC resistance profile. Thirty-five (40%) of the isolates possessed class 1 integrons. Sequence analyses of the integrons showed that they contained aadA, which confers resistance to streptomycin, or aadA and dhfr, which confer resistance to trimethoprim-sulfamethoxazole. One integron from a swine isolate contained the sat-1 gene, which encodes resistance to streptothricin, an antimicrobial agent that has never been approved for use in the United States. In conclusion, Salmonella serotype Newport MDR-AmpC was commonly identified among Salmonella serotype Newport isolates recovered from humans and food animals. These findings support the possibility of transmission of this organism to humans through the food chain.Keywords
This publication has 22 references indexed in Scilit:
- Molecular Characterization of Cephalosporin-Resistant Salmonella enterica Serotype Newport Isolates from Animals in PennsylvaniaJournal of Clinical Microbiology, 2002
- Morbidity of Infections Caused by Antimicrobial‐Resistant BacteriaClinical Infectious Diseases, 2002
- Identification and Expression of Cephamycinase bla CMY Genes in Escherichia coli and Salmonella Isolates from Food Animals and Ground MeatAntimicrobial Agents and Chemotherapy, 2001
- Identification and Characterization of Integron-Mediated Antibiotic Resistance among Shiga Toxin-Producing Escherichia coli IsolatesApplied and Environmental Microbiology, 2001
- Nontyphoidal SalmonellosisClinical Infectious Diseases, 2001
- Animal and Human Multidrug-Resistant, Cephalosporin-Resistant Salmonella Isolates Expressing a Plasmid-Mediated CMY-2 AmpC β-LactamaseAntimicrobial Agents and Chemotherapy, 2000
- Ceftriaxone-Resistant Salmonella Infection Acquired by a Child from CattleNew England Journal of Medicine, 2000
- Food-Related Illness and Death in the United StatesEmerging Infectious Diseases, 1999
- Characterisation of CMY-4, an AmpC-type plasmid-mediated β-lactamase in a Tunisian clinical isolate ofProteus mirabilisFEMS Microbiology Letters, 1998
- Emergence of Multidrug-ResistantSalmonella entericaSerotypeTyphimurium DT104 Infections in the United StatesNew England Journal of Medicine, 1998